Kidney Disease Clinical Trials in Phoenix

Showing 321-327 of 327 trials

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

NCT00048451

The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease.

Renal Insufficiency, Chronic

Abbott68 participantsStarted Feb 2002

Tucson, Arizona, United States • Pasadena, California, United States • San Diego, California, United States +16 more locations

COMPLETEDPhase 3256 miles

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

NCT00646035

To determine the safety and efficacy of paricalcitol capsules as compared to placebo for treatment of secondary hyperparathyroidism by decreasing serum intact parathyroid hormone levels in end stage renal disease subjects on peritoneal dialysis.

End Stage Renal Disease

Abbott75 participantsStarted Jan 2002

Los Angeles, California, United States • Denver, Colorado, United States • Washington D.C., District of Columbia, United States +21 more locations

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

Kidney Disease Trials in Other Cities

Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis

YSPSL for Prevention of Delayed Graft Function Part B

Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma

Other Conditions in Phoenix